This compound is a pharmaceutical intermediate used in the manufacturing of elagolix, featuring a complex molecular structure containing multiple aromatic rings, ether groups, and halogens.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 830346-51-5
Elagolix
GnRH antagonist active pharmaceutical ingredient
1,1-Dimethylethyl N-[(1R)-2-[5-bromo-3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-3,6-dihydro-4-methyl-2,6-dioxo-1(2H)-pyrimidinyl]-1-phenylethyl]carbamate
pharmaceutical intermediate
Elagolix sodium
gonadotropin-releasing hormone antagonist
Benzoic acid, 2,4-difluoro-, ion(1-)
Pharmaceutical intermediate
3,5-Dimethylisoxazole-4-boronic acid pinacol ester
pharmaceutical intermediate
2-(3-(Carboxymethyl)-4-(phenylthio)phenyl)propanoic acid
Zatoprofen intermediate anti-inflammatory
(1R,5S)-8-Benzyl-8-azabicyclo(3.2.1)octan-3-one hydrochloride
pharmaceutical intermediate
Ethyl 4-(((1R)-2-(5-(2-fluoro-3-methoxyphenyl)-3-(2-fluoro-6-(trifluoromethyl)benzyl)-4-methyl-2,6-dioxo-3,6-dihydro-1(2H)-pyrimidinyl)-1-phenylethyl)amino)butanoate
Elagolix intermediate
tert-butyl N-[(1R)-2-[5-(2-fluoro-3-methoxyphenyl)-3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-4-methyl-2,6-dioxopyrimidin-1-yl]-1-phenylethyl]carbamate
UOUIRPGFUIEVPG-VWLOTQADSA-N
CC1=C(C(=O)N(C(=O)N1CC2=C(C=CC=C2F)C(F)(F)F)C[C@@H](C3=CC=CC=C3)NC(=O)OC(C)(C)C)C4=C(C(=CC=C4)OC)F